CasNo.5843-65-2,DL-Demethylcoclaurine,Demethyl-Coclaurine(5843-65-2) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: 98%min
Payment Terms : L/C|T/T|Westem Union||Other

Keywords

Quick Details

Appearance:off-white powder
Application:They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue dis
PackAge:1kg/foil bag; 25kg/drum
ProductionCapacity:10|Metric Ton/Month
Storage:keep in dry cold place
Transportation:BY SEA OR AIR

Superiority:

CASNumber: 5843-65-2 Name: 6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]- SuperlistN…

Details:

CAS Number:

5843-65-2

Name:

6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-

Superlist Name:

DL-Demethylcoclaurine

Molecular Structure:

Formula:

C₁₆H₁₇NO₃

Molecular Weight:

271.31

Synonyms:

6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-, (?à)-;Coclaurine, O-demethyl-, (?à)- (8CI);(RS)-Norcoclaurine;1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol;(±)-HIGENAMINE;1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydro-6,7-isoquinolinediol;Higenamine;dl-Demethylcoclaurine;6,7-isoquinolinediol, 1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-;6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (±)-;Isoquinolin-6,7-diol, 1,2,3,4-tetrahydro-1-[4-hydroxybenzyl]-;

Density:

1.317 g/cm³

Boiling Point:

522.4 °C at 760 mmHg

Flash Point:

209.6 °C

【Pharmacological Action】: - Drugs that selectively bind to and activate beta-adrenergic receptors.
- Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain NSAIDs also may inhibit lipoxygenase enzymes or TYPE C PHOSPHOLIPASES or may modulate T-cell function. (AMA Drug Evaluations Annual, 1994, p 1814-5)
- Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
- Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.